These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11472578)
1. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival. Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578 [TBL] [Abstract][Full Text] [Related]
2. Serum levels and differential expression of intercellular adhesion molecule-1 in childhood leukemia and malignant lymphoma: prognostic importance and relationship with survival. Tacyildiz N; Yavuz G; Gozdasoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Ensari A; Okcuoglu-Cavdar A Pediatr Hematol Oncol; 1999; 16(2):149-58. PubMed ID: 10100275 [TBL] [Abstract][Full Text] [Related]
3. Serum osteopontin and CD44 levels in lymphoreticular malignancies in children. Elli M; Dagdemir A; Bozkurt C; Pinarli FG; Duzgun A; Ozmen ZC; Ertem U; Acar S Bratisl Lek Listy; 2012; 113(9):534-8. PubMed ID: 22979908 [TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma. Sasaki K; Niitsu N Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056 [TBL] [Abstract][Full Text] [Related]
5. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia. Amirghofran Z; Asiaee E; Kamazani FM Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983 [TBL] [Abstract][Full Text] [Related]
6. Serum soluble CD44 in pediatric patients with acute leukemia. Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451 [TBL] [Abstract][Full Text] [Related]
7. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients? Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma. Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314 [TBL] [Abstract][Full Text] [Related]
9. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors. Ahmed MI; Hassab HM Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693 [TBL] [Abstract][Full Text] [Related]
10. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma. Niitsu N; Iijima K Leuk Res; 2002 Mar; 26(3):241-8. PubMed ID: 11792412 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of some biochemical markers as prognostic factors in malignant lymphoma. Khalifa KA; Alkilani AA; Ismail H; Soliman MA J Egypt Natl Canc Inst; 2008 Mar; 20(1):47-54. PubMed ID: 19847281 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139 [TBL] [Abstract][Full Text] [Related]
13. Serum Ca 125 levels in children with acute leukemia and lymphoma. Birgen D; Ertem U; Duru F; Sahin G; Yüksek N; Bozkurt C; Karacan CD; Aksoy C Leuk Lymphoma; 2005 Aug; 46(8):1177-81. PubMed ID: 16085559 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis. Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973 [TBL] [Abstract][Full Text] [Related]
15. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia]. Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397 [TBL] [Abstract][Full Text] [Related]
16. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma. Abdelrazik N; Fouda M; Zaghloul MH; Abbas D Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393 [TBL] [Abstract][Full Text] [Related]
17. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H; Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465 [TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1(ICAM-1), CD44s expression and serum level of sICAM-1 in disseminated non-Hodgkin's lymphoma: correlation with overall survival. Aboul-Enein M; El-Sayed GM; El-Maghraby S; Abd-Elatif NA; Abd Elwahab GA; Elbasmy AA J Egypt Natl Canc Inst; 2004 Dec; 16(4):244-51. PubMed ID: 16116502 [TBL] [Abstract][Full Text] [Related]
19. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes. Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788 [TBL] [Abstract][Full Text] [Related]